Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Gain Therapeutics (GANX) Q2 2025 Earnings
GANX
14
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.42
-0.31
-0.19
-0.08
Details
Expected EPS
-0.179825
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+11.02%
Description
Gain Therapeutics (GANX) has reported earnings of -0.16 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login